Description
Developer of a platform technology intended to treat vascular diseases. The company's technology is developed for the treatment of cardiovascular ischemic disease using combinations of gene and stem cell procedures, enabling patients suffering from vascular diseases gets the required treatment.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Accelerator/Incubator | 13-Aug-2014 | $300K | 00000 | Completed | Generating Revenue | |
2. Angel (individual) | Completed | Startup | ||||
1. Grant | $10M | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Keith Webster Ph.D | Founder and President |
Name | Representing | Role | Since |
---|---|---|---|
Eduardo De Marchenna MD | Integene International | Board Member | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Institute for Commercialization of Florida Technology | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | |
National Institutes of Health | Government | 000 0000 | 000000 0 |